Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Protein-tyrosine-phosphatases (PTPases) play crucial roles in cellular signaling.
• Epidermal growth factor (EGF) is a key regulator of cell growth and proliferation.
• Dysregulation of PTPase activity is implicated in various cancers.

Purpose of the Study:

• To investigate the regulation of PTPase activity by EGF.
• To identify specific substrates dephosphorylated by EGF-stimulated PTPase.
• To explore the physiological relevance of this regulation in cancer cells.

Main Methods:

• Utilized cytosol from EGF-treated A-431 human epidermoid carcinoma cells.
• Employed tyrosine-phosphorylated ErbB2, EGF receptor, phospholipase C-gamma 1, and Ras GTPase-activating protein as substrates.
• Assessed PTPase activity in vitro, examining effects of reducing agents and orthovanadate.

Main Results:

• EGF significantly stimulated PTPase activity selectively towards ErbB2 and the EGF receptor.
• EGF-induced PTPase activity dephosphorylated ErbB2 and EGF receptor but not other tested substrates.
• This EGF-stimulated PTPase activity was observed across multiple cell lines and localized to the cytosol.
• In vitro activity required reducing agents and was inhibited by orthovanadate.
• EGF treatment rapidly induced ErbB2 dephosphorylation in a human mammary cancer cell line.

Conclusions:

• EGF regulates PTPase activity, leading to selective dephosphorylation of key signaling proteins.
• This mechanism highlights a novel regulatory pathway for growth factor signaling in cancer.
• The findings suggest a potential therapeutic target for cancers driven by aberrant growth factor signaling.